These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23128493

  • 1. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Hu M, Liu Q, Song P, Zhan X, Luo M, Liu C, Yang D, Cai Y, Zhang F, Jiang F, Zhang Y, Tang M, Zuo G, Zhou L, Luo J, Shi Q, Weng Y.
    Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
    [Abstract] [Full Text] [Related]

  • 2. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

  • 3. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K, Mohri Y, Ohi M, Yokoe T, Koike Y, Morimoto Y, Miki C, Tonouchi H, Kusunoki M.
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
    Mitra M, Kandalam M, Sundaram CS, Verma RS, Maheswari UK, Swaminathan S, Krishnakumar S.
    Invest Ophthalmol Vis Sci; 2011 Jul 23; 52(8):5441-8. PubMed ID: 21546534
    [Abstract] [Full Text] [Related]

  • 13. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S, Miyata H, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Ann Surg Oncol; 2015 Dec 23; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [Abstract] [Full Text] [Related]

  • 14. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
    Zhang JX, Tong ZT, Yang L, Wang F, Chai HP, Zhang F, Xie MR, Zhang AL, Wu LM, Hong H, Yin L, Wang H, Wang HY, Zhao Y.
    Int J Cancer; 2013 Jun 01; 132(11):2567-77. PubMed ID: 23132660
    [Abstract] [Full Text] [Related]

  • 15. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 01; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
    Rong F, Li W, Chen K, Li DM, Duan WM, Feng YZ, Li F, Zhou XW, Fan SJ, Liu Y, Tao M.
    Neoplasma; 2012 Mar 01; 59(5):541-50. PubMed ID: 22668020
    [Abstract] [Full Text] [Related]

  • 17. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A, Faried LS, Kimura H, Sohda M, Nakajima M, Miyazaki T, Kato H, Kanuma T, Kuwano H.
    Cancer Chemother Pharmacol; 2006 Feb 01; 57(3):301-8. PubMed ID: 16028102
    [Abstract] [Full Text] [Related]

  • 18. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
    Ha GH, Baek KH, Kim HS, Jeong SJ, Kim CM, McKeon F, Lee CW.
    Cancer Res; 2007 Aug 01; 67(15):7155-64. PubMed ID: 17671183
    [Abstract] [Full Text] [Related]

  • 19. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y, Yang Z, Li Q, Song F.
    Oncology; 2008 Aug 01; 74(3-4):198-206. PubMed ID: 18714168
    [Abstract] [Full Text] [Related]

  • 20. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
    Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F, Ishii H, Okumura H, Natsugoe S, Mori M.
    Ann Surg Oncol; 2011 Jan 01; 18(1):261-72. PubMed ID: 20734150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.